Gapping down
In reaction to earnings/guidance:
- FFIV -13.2%, NAVI -10.4%, KMB -4.7%, OSK -3%, FBC -2.9%, CNI -1.6% (also names new CEO; also approves new C$5 bln normal course issuer bid; increases dividend by 19%; announces resolution agreement with TCI), QCRH -1.4%, TEL -1.4%, ANTM -1%, GD -0.9%, BA -0.8%
Other news:
- MYNZ -23.3% (prices follow-on offering of 1.5 mln shares of stock at $15.00 per share)
- SRRA -4.2% (stock offering)
- AGFY -3.7% (entered into securities purchase agreements with an institutional investor and other accredited investors in a private placement transaction)
- MRUS -3.3% (MRUS regains worldwide rights to MCLA-145 from INCY)
- HAS -2.4% (Mattel confirms license agreement with Disney (DIS) for Disney Princess and Disney Frozen franchises)
- GILD -2.1% (receives Partial Clinical Hold from FDA for studies evaluating Magrolimab in combination with Azacitidine)
- EGHT -1.1% (stock offering)
Analyst comments:
- NLSN -3.9% (downgraded to Sell from Neutral at Goldman)
- HTLD -1.3% (downgraded to Underweight from Equal Weight at Barclays)